Gliclazide Retard Mylan 30 mg tabl. modif.-rel.

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Gliclazide 30 mg

MAH:

Viatris GX BV-SRL

ATC_code:

A10BB09

pharmaceutical_form:

Modified-release tablet

administration_route:

Oral use

therapeutic_area:

Gliclazide

leaflet_short:

CTI Extended: 345651-01; 345651-02; 345651-03

authorization_status:

Commercialised: No

authorization_date:

2009-08-13